Simvastatin Effect on Radiation Therapy of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
- Status
- TERMINATED
- Phase
- PHASE2
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Toronto BNB Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1
Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
- Status
- COMPLETED
- Phase
- N/A
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases
- Status
- COMPLETED
- Phase
- NA
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
- Status
- TERMINATED
- Phase
- NA
STAR Cape+BKM120 MBC With Brain Met
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Proof-of-principle Study of HBO-SRS for Brain Metastases
- Status
- COMPLETED
- Phase
- NA
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
- Status
- TERMINATED
- Phase
- NA
Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
- Status
- WITHDRAWN
- Phase
- NA